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Since 8th October when the government announced that a dis- 
ussion to approve emergency contraceptive pills (ECPs) for non- 
rescription provision will be restarted in Japan [1] , heated de- 
ates over the issue have reignited in the mainstream and social 
edia. Why has improving access to ECPs become so controversial 
n Japan? 
Currently, access to ECPs in Japan requires a medical prescrip- 
ion and a pill costs around 60 0 0 to 20,0 0 0 yen (55–190 USD),
hich is unacceptably expensive for many women. This is because 
ontraception is not covered by national health insurance and the 
rice is set at the discretion of each medical facility. Currently only 
% of hospitals and clinics declare that they provide consultation 
or ECPs and of those, only a few extended opening hours [2] . 
oncerns over unintended pregnancy increased amid the COVID- 
9 pandemic where consultations for unintended pregnancy and 
exual violence increased significantly [3] . 
The World Health Organization (WHO) states that it is a right of 
ll women and girls at risk of an unintended pregnancy to access 
mergency contraception. Considering its safety and higher effec- 
iveness in earlier use after unprotected sex, the WHO and the In- 
ernational Federation of Gynecology and Obstetrics (FIGO) recom- 
end non-prescription provision of ECPs [ 4 , 5 ]. Currently, 19 coun- 
ries allow direct access to ECPs over the counter and 76 countries 
rom a pharmacist without a prescription. 
In response to public demand for over-the-counter (OTC) use, 
he MHLW considered approval of non-prescription provision of 
CPs in 2017 [6] . Despite receiving overwhelming public support, 
he plan did not pass due to concerns raised by the review com- 
ittee including that users might not have enough “literacy” to ad- ∗ Corresponding author at: School of Tropical Medicine and Global Health, Na- 
asaki University, 1-14 Bunkyomachi, Nagasaki 852-8521, Japan. 





ttps://doi.org/10.1016/j.lanwpc.2021.10 0 095 
666-6065/© 2021 The Authors. Published by Elsevier Ltd. This is an open access article uquately use it and that it might lead to “misuse” or “abuse” [6] . 
oncerns were raised mainly by the Japanese Association of Obste- 
ricians and Gynecologists (JAOG) [6] . 
First is a safety concern. The review committee discussed that 
t is necessary for physicians with “specialized knowledge of repro- 
uctive endocrinology” to determine who is eligible and to follow- 
p after use because users might not be able to notice pregnancy 
n case of ECP failure [6] . Is the safety concern substantial enough 
o necessitate specialist screening and regular follow-up? Although 
CPs are not indicated for a woman who is already pregnant, cur- 
ent evidence suggests that ECPs do not harm a fetus [5] . The WHO
nd major societies of obstetricians and gynaecologists do not rec- 
mmend provider screening or regular follow-up because ECPs are 
afe for all women and should not be delayed for screening and 
regnancy test [ 4 , 5 , 7 ]. 
Secondly, there is an argument that increased access to ECPs 
ight discourage condom use and increase sexually transmitted 
nfections. However, there is no evidence that providing advance 
CPs to adolescents is associated with more unprotected inter- 
ourse or less condom or hormonal contraception use [8] . 
The third concern is about abuse or misuse. In 2019, the JAOG 
ade a written statement [9] that “women seeking emergency 
ontraceptives, or people behind them, may be involved in the sex 
ndustry or a criminal organization who might transfer drugs to 
ther”. They continue that thus it is desirable to limit prescrip- 
ion to one set at a time and make women take the pill on the
pot. This recommendation of directly observed use based on sus- 
icion that women might abuse the medication is unbearable and 
roblematic. This argument is clearly going against international 
vidence-based recommendations by WHO and FIGO that encour- 
ge advance supply since studies show that women given ECPs be- 
orehand were more likely to use them when needed and to take 
hem sooner [ 4 , 5 ]. nder the CC BY license ( http://creativecommons.org/licenses/by/4.0/ ) 


























Historically, Japan was the only United Nations member pro- 
ibiting the use of low-dose oral contraceptives (OCs) until 1999 
hen approval was given after approximately 44 years of de- 
ate [ 10 , 11 ]. Current discussion of ECPs remind us of the debate
ver OCs approval where gender-biased and paternalistic argu- 
ents were made such as “OCs would deteriorate sexual morality 
r spread sexually transmitted infections” [10] . 
This is an urgent issue since there are women on a day-to-day 
asis with immediate need of this essential medication. A petition 
or approving ECPs for non-prescription provision has gained more 
han 107,0 0 0 signatures to date up (15 Nov 2020) [12] . Policy mak-
rs and specialist advisory groups should listen to the voices of 
eople and to make an evidence-based decision. 
ontributions 
SE designed the overall structure of manuscript. SS analyzed the 
ata and drafted the early version of the manuscript. CS gave com- 
ents on the earlier versions of the manuscript. All authors edited 
he manuscript and approved the final version. 
eclaration of Competing Interest 
The authors declare no conflicts of interest. 
ole of funding source 
SS is supported by WISE Program (Doctoral Program for World- 
eading Innovative & Smart Education) of Ministry of Education, 
ulture, Sports, Science and Technology. The funders had no role 
n study design, data collection and analysis, decision to publish, 
r preparation of the manuscript. 
eferences 
[1] Y. Nippo. Emergency contraceptives without prescription - government to con- 
sider pharmacy purchase. 2020 Oct 12; Available from: https://www.yakuji.co. 
jp/entry82177.html 2 [2] Ministry of Health Labor and Welfare J. Measurement for emergency contra- 
ception [Internet]. 2020 [cited 2020 Nov 21]. Available from: https://www. 
mhlw.go.jp/stf/seisakunitsuite/bunya/0 0 0 0186912 _ 0 0 0 02.html 
[3] Asahi. Sexual violence counseling up 15% under COVID-19, dating through so- 
cial networking sites may be a factor. Asahi Shinbun [Internet]. 2020 Nov 7; 
Available from: https://www.asahi.com/articles/DA3S14686577.html 
[4] World Health Organization W. Emergency contraception [Internet]. 2018 [cited 
2020 Nov 14]. Available from: https://www.who.int/en/news-room/fact-sheets/ 
detail/emergency-contraception 
[5] Ginecology and Obstetrics IF of, Emergency contraception IC. Medical and 
service delivery guidance: emergency contraceptive pills. [Internet]. 2018. 
p. 24. Available from: https://www.cecinfo.org/wp-content/uploads/2018/12/ 
ICEC-guides _ FINAL.pdf 
[6] Ministry of Health Labor and Welfare J. Results of the review conference 
on the appropriateness of the requested ingredient for switch OTC [Inter- 
net]. 2017 [cited 2020 Nov 15]. Available from: https://www.mhlw.go.jp/file/ 
06- Seisakujouhou- 11120 0 0 0-Iyakushokuhinkyoku/0 0 0 0193402.pdf 
[7] The American College of Obstetricians and Gynecologists APractice bulletin 
no. 152: emergency contraception. Obstet Gynecol 2015;126(3):e1–11. [Inter- 
net].Available from: http://www.ncbi.nlm.nih.gov/pubmed/26287787 . 
[8] Adamji JM , Swartwout K . Integrative review: advance provision of emergency 
contraception for adolescents. J Sch Nurs 2010;26(6):443–9 . 
[9] Japan Association of Obstetricians and Gynechologists J. Opinion on online 
prescription of emergency contraceptives. 2019; Available from: https://www. 
mhlw.go.jp/content/108030 0 0/0 0 0496180.pdf 
10] Watts J. TOKYO when impotence leads contraception. Lancet 
1999;353(9155):819. [Internet].Available from: https://linkinghub.elsevier. 
com/retrieve/pii/S0140673605764886 . 
11] Claeys V. Brave and angry – the creation and development of the interna- 
tional planned parenthood federation (IPPF). Eur J Contracept Reprod Health 
Care 2010;15(sup2):S67–76. [Internet]Available from: http://www.tandfonline. 
com/doi/full/10.3109/13625187.2010.526726 . 
12] Someya A. Bring emergency contraceptive to every woman who needs 
it!. Changeorg; 2020. [Internet][cited 2020 Nov 15]. Available from: 
https://www.change.org/p/%E3%82%A2%E3%83%95%E3%82%BF%E3%83%BC% 
E3%83%94%E3%83%AB-%E7%B7%8A%E6%80%A5%E9%81%BF%E5%A6%8A%E8%96% 
AC-%E3%82%92%E5%BF%85%E8%A6%81%E3%81%A8%E3%81%99%E3%82%8B%E3% 
81%99%E3%81%B9%E3%81%A6%E3%81%AE%E5%A5%B3%E6%80%A7%E3%81%AB% 
E5%B1%8A%E3%81%91%E3%81%9F%E3%81%84?redirect=false . 
